BridgeMD
Compares treatment options for Myopia
Official title Contoura With Phorcides Compared to Wavefront Optimized LASIK
ClinicalTrials.gov ID: NCT05486546
What this study is testing
- What it's testing
- Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 38
You may be able to join if
- Patients at least age 21 years of age undergoing LASIK eye surgery
- Willing and able to comprehend informed consent and complete 1 month post-op visit
- Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
- Candidates for Contoura with Phorcides (Myopic, astigmatism \<3.0D)
- Both eyes targeted for plano
You likely can't join if
- Patients under 21 years of age
- Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
- Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled...
- Pachymetry below 490
- Autoimmune or immunodeficiency diseases
- Pregnant or nursing women
See the full eligibility criteria
- Patients at least age 21 years of age undergoing LASIK eye surgery
- Willing and able to comprehend informed consent and complete 1 month post-op visit
- Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
- Candidates for Contoura with Phorcides (Myopic, astigmatism \<3.0D)
- Both eyes targeted for plano
- Pre-operative total corneal Pachymetry 490um or above
- Stable refractive error \<0.50D change in preceding year
- Good general and ocular health
- Pre-operative exam completed within three months of surgery
- SCL discontinued 3 days prior to pre-op exam and the procedure
- Pachymetry above 490 with residual greater than 270um
- Candidates who, as determined by the investigator, can safely undergo LASIK
- Patients under 21 years of age
- Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
- Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of...
- Pachymetry below 490
- Autoimmune or immunodeficiency diseases
- Pregnant or nursing women
- Patients with signs of inability to understand consent for study and procedure planned
- Patients with history of previous ocular surgery
- Patients with strabismus or amblyopia
- Patients that have a BCDVA of 20/25 or worse in either eye
The study team makes the final eligibility decision.
Where it's taking place
- Bozeman, Montana, United States
- Omaha, Nebraska, United States
- Fargo, North Dakota, United States
- Sioux Falls, South Dakota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bozeman, Montana, United States; Omaha, Nebraska, United States; Fargo, North Dakota, United States; Sioux Falls, South Dakota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.